Tetraphase Pharmaceuticals to Present at Upcoming Investor Conferences
November 07 2018 - 6:00AM
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical
company focused on developing and commercializing novel antibiotics
to treat life-threatening multidrug-resistant (MDR) infections,
today announced that President and Chief Executive Officer Guy
Macdonald will present a corporate overview at the Stifel 2018
Healthcare Conference on Wednesday, November 14, 2018 at 8:00 a.m.
ET at Lotte New York Palace Hotel in New York City. Mr. Macdonald
also will participate in a fireside chat at the Piper Jaffray 30th
Annual Healthcare Conference on Tuesday, November 27, 2018 at 2:30
p.m. ET at the Lotte New York Palace Hotel in New York City.
A live audio webcast of the Stifel 2018
Healthcare Conference presentation will be available on the
Company’s website at
https://tphase.gcs-web.com/events-presentations. The archived
presentation will be available for 30 days.
About Tetraphase Pharmaceuticals,
Inc.Tetraphase is a biopharmaceutical company using its
proprietary chemistry technology to create novel antibiotics for
serious and life-threatening bacterial infections, including those
caused by many of the multidrug-resistant bacteria highlighted as
urgent public health threats by the World Health Organization and
the Centers for Disease Control and Prevention. The Company has
created more than 3,000 novel tetracycline compounds using its
proprietary technology platform. Tetraphase's lead product
XERAVA™ (eravacycline) is approved for the treatment of
complicated intra-abdominal infections by the U.S. Food and Drug
Administration and the European Medicines Agency. The Company’s
pipeline also includes TP-271 and TP-6076, which are in Phase 1
clinical trials. Please visit www.tphase.com for more company
information.
Media and Investor Contact:Tetraphase
PharmaceuticalsJennifer Viera617-600-7040jviera@tphase.com
Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Historical Stock Chart
From Jul 2024 to Jul 2024
Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Historical Stock Chart
From Jul 2023 to Jul 2024